Executive View
As of 9 Oct 2026
Findings raised fell to 12 in Q3 2026 from 16 in Q2 2026, and high-severity findings went from 7 to 5. Control exceptions decreased from 13 to 8; open findings are concentrated in SAP S/4HANA (5).
Remediation is not holding: 5 of the 16 Q2 2026 remediations failed retest. Evidence approval in Q3 2026 rose to 77% from 50% in Q2 2026, with 19 items awaiting review.
Continuous monitoring shows 8 findings.
Overall, all 4 period-on-period metrics changed; none moved adversely. Remediation retest and monitoring have no prior-period trend and are reported above.
AI-generated from assurance records — review before use.
Findings raised fell from 16 in Q2 2026 to 12 in Q3 2026.
Investigate →High-severity findings fell from 7 in Q2 2026 to 5 in Q3 2026.
Investigate →Failed control tests fell from 13 in Q2 2026 to 8 in Q3 2026.
Investigate →5 of the 16 Q2 2026 remediations failed retest; 9 Q3 2026 retests are still pending.
Investigate →